Denali Therapeutics (DNLI) Return on Invested Capital (2019 - 2023)

Denali Therapeutics (DNLI) has 5 years of Return on Invested Capital data on file, last reported at 0.0% in Q4 2023.

• Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital eased to 0.0% in Q4 2023 per DNLI's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.0% in Q4 2020 and bottomed at 0.0% in Q1 2020.
• The 5-year median for Return on Invested Capital is 0.0% (2019), against an average of 0.0%.
• The widest annual swing landed in 2020, when Return on Invested Capital changed 0 bps; it then grew 1 bps in 2021.
• Tracing DNLI's Return on Invested Capital over 5 years: stood at 0.0% in 2019, then soared by 135 bps to 0.0% in 2020, then slumped by 590 bps to 0.0% in 2021, then retreated by 22 bps to 0.0% in 2022, then jumped by 50 bps to 0.0% in 2023.
• Per Business Quant, the three latest DNLI Return on Invested Capital figures stand at 0.0% (Q4 2023), 0.0% (Q3 2023), and 0.0% (Q2 2023).

Peer Comparison